Highland Instruments Named Finalist in Massachusetts Innovation Network's 2025 Eddies Awards

CAMBRIDGE, Mass. - EntSun -- Highland Instruments is honored to be selected as a finalist in the 2025 Eddies Awards by the Massachusetts Innovation Network, a program that celebrates and supports some of the commonwealth's most promising emerging technology companies. Highland is one of only three finalists in the Medical Devices category.

Inspired by Thomas Edison, the Eddies is the northeast's longest running innovation competition. Eddies finalists spend 5 months engaging in a no-cost, no-equity program offering tailored mentoring, strategic guidance, leadership development, and access to funding and other resources.

Highland Instruments is developing ESStim™ - a novel noninvasive brain stimulation platform to help patients address movement disorders. As an Eddies finalist, Highland will leverage the program's resources to achieve milestones related to customer insights, quality systems, reimbursement strategy, and investor engagement.

More on EntSun News

• AIRSED Launches Revolutionary AI-Driven Financial Analysis Platform, Democratizing Elite Investment Tools for Global Markets
• Bertram Sanders Jr. Earns Best Television Script at Prestigious LA Film Awards
• Galveston Juneteenth Birthplace Website Launches to Connect Culture & Celebrate Juneteenth 2025
• Real Estate CEO Launches Explosive New Book After $275,784 Wire Fraud Incident
• TEDxInglewood Returns to The Miracle Theater on August 9, 2025 — Celebrating Bold Ideas and Community Energy

"We are honored to receive this recognition from Massachusetts Innovation Network, and we are excited about the opportunity to contribute to Massachusetts' heritage of MedTech innovation," said Dr. Tim Wagner, Highland Instruments' Founder and Chief Scientific Officer.

"ESStim™ has the potential to improve treatment for Parkinson's Disease patients. We are grateful for being selected as an Eddies finalist and look forward to participating in the program to advance ESStim™'s development," stated Dr. Laura Dipietro, Highland's Chief Technology Officer.

"Our selection as an Eddies finalist is a testament to Highland's innovation and potential impact," stated Alex Herzlinger, Highland's Chief Business Officer. "We appreciate the Massachusetts Innovation Network for the selection, and we look forward to working with the Eddies program to achieve milestones towards ESStim™'s commercialization."

About Highland Instruments
Highland Instruments is developing ESStim™ - a novel noninvasive brain stimulation platform to help patients address movement disorders. Learn more at www.highlandinstruments.com (https://www.highlandinstruments.us/).

ESStim™ has not been approved by the Food and Drug Administration for a specific clinical indication. This technology is not in commercial distribution in the United States or inter­nationally. Please contact Highland Instruments for additional information regarding this technology and potential clinical application.